Methionine–tRNA ligase, cytoplasmic

MARS1
Identifiers
AliasesMARS1, METRS, MRS, MTRNS, SPG70, CMT2U, ILFS2, ILLD, methionyl-tRNA synthetase, methionyl-tRNA synthetase 1, MARS, TTD9
External IDsOMIM: 156560; MGI: 1345633; GeneCards: MARS1
Available structures
PDBOrtholog search: PDBe RCSB
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
6.1.1.10↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_004990

NM_001003913
NM_001171582

RefSeq (protein)

NP_004981

NP_001003913
NP_001165053

Location (UCSC)Chr 12: 57.48 – 57.52 MbChr 10: 127.13 – 127.15 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Methionine–tRNA ligase, cytoplasmic, also called methionyl-tRNA synthetase 1, is an enzyme that in humans is encoded by the MARS1 gene (formally MARS). Like to the related enzyme, MARS2, this enzyme function as a Methionine–tRNA ligase. This means it attaches the amino acid methionine to the corresponding transfer RNA (tRNAMet) which is a preparation step for RNA-to-protein translation.

Aminoacyl-tRNA synthetases are a class of enzymes that charge tRNAs with their cognate amino acids. The protein encoded by this gene belongs to the class I family of tRNA synthetases.

Medical significance

Pathogenic mutations in MARS1 have been associated with associated with a variety of illnesses. Heterozygous (loss-of-function) mutations have been associated with a form of Charcot-Marie-Tooth disease type 2U (CMT2U), while homozygous or compound heterozygous mutations have been associated with either Interstitial lung and liver disease (ILLD) or autosomal recessive spastic paraplegia-70 (SPG70).